{"transactions":[{"id":819822,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T22:00:20.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":425700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":425700,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":425700},"source":{"system":"sec-edgar","filing":"0001965590-26-000002","document":"form4-04022026_060414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000196559026000002/form4-04022026_060414.xml","form_type":"4"}},{"id":1236085,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-03-03T22:00:44.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":488800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":488800,"derivative":{"exercise_price":1.2,"expiration_date":"2035-02-27","underlying":"Class A Ordinary Shares","underlying_shares":488800},"source":{"system":"sec-edgar","filing":"0001415889-25-006199","document":"form4-03032025_100340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925006199/form4-03032025_100340.xml","form_type":"4"}},{"id":1319892,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-12-31T21:15:04.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Member"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award, which vested in full immediately upon grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by the Reporting Person's family member. The Reporting Person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001415889-24-030312","document":"form4-12312024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924030312/form4-12312024_041201.xml","form_type":"4"}},{"id":1319891,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-12-31T21:15:04.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Member"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award, which vested in full immediately upon grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by the Reporting Person's family member. The Reporting Person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001415889-24-030312","document":"form4-12312024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924030312/form4-12312024_041201.xml","form_type":"4"}},{"id":1472207,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:10:17.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":420000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001415889-24-017863","document":"form4-06212024_060612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017863/form4-06212024_060612.xml","form_type":"4"}},{"id":1882811,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2023-05-23T01:16:25.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":492381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an award of 492,381 Restricted Share Units (\"RSUs\") on May 18, 2023 (the \"Grant Date\"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":492381,"source":{"system":"sec-edgar","filing":"0001104659-23-063313","document":"tm2316481-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063313/tm2316481-3_4seq1.xml","form_type":"4"}}]}